Myeloid Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors (NCT07334119) | Myeloid Therapeutics | 2025-11-25 |
| A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC (NCT06478693) | Myeloid Therapeutics | 2024-07-01 |
| Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors (NCT05969041) | Myeloid Therapeutics | 2023-08-02 |
| A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL (NCT05138458) | Myeloid Therapeutics | 2021-12-15 |
Track Myeloid Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.